The Ghana Health Service (GHS), in collaboration with the United Nations Children’s Fund (UNICEF), is set to roll out the nationwide administration of the Human Papillomavirus (HPV) vaccine in September 2025.
The vaccine will be provided free of charge to girls aged 9 to 14 years across the country, as part of a strategic national effort to reduce the burden of cervical and other HPV-related cancers.
Speaking at a press briefing held at the Korle Bu Teaching Hospital on 20 June 2025, Director-General of the GHS, Professor Samuel Kaba Akoriyea, described the vaccine as a game-changer in cancer prevention.
“It is estimated that the HPV vaccine may prevent 70% of cervical cancers, 80% of anal cancers, 60% of vaginal cancers and is more than 90% effective in preventing HPV-positive oropharyngeal cancers,” he stated.
He recalled the vaccine’s pilot introduction in 2013 in selected regions—Greater Accra, Central, and Northern—and expressed confidence in the service’s readiness for nationwide implementation.
“Twelve years after the initial rollout, we are ready to expand it to every region to protect our future mothers,” Prof Akoriyea said. “By vaccinating girls aged 9 to 14, we are giving them a head start towards a healthier, cancer-free adulthood.”
He assured the public that the HPV vaccines are “safe and well tolerated.”
Deputy Programme Manager of the Expanded Programme on Immunisation (EPI), Dr Naziru Tanko Mohammed, reinforced the assurances with data and a clear plan of action. He noted that the goal is to vaccinate an estimated 2,463,889 girls nationwide, adding that the vaccine has been “extensively tested,” is “safe,” and requires only “one dose for full protection.”
Dr Mohammed stated that all logistical arrangements have been finalised to support the campaign.
“Currently, the vaccines are being stored in the national cold room. From there, they will be moved to the regional cold rooms in preparation for the vaccination exercise,” he explained.
Parents and guardians were encouraged to take advantage of the programme when it begins, with assurances that school authorities would be duly informed and supported to facilitate smooth implementation.
HPV has been identified as the primary cause of cervical cancer, which is the second leading cause of cancer deaths among women in Ghana.
The Ghana Health Service reiterated its commitment to raising public awareness and urged community support to ensure the success of the campaign and the long-term health of Ghanaian girls.
In a powerful show of solidarity and social impact, Access Bank Holdings, the parent company of Access Bank (Ghana) PLC, has launched a coordinated blood donation drive across all its operating countries.
The initiative is part of the bank’s broader Corporate Social Responsibility (CSR) efforts and commemorates World Sickle Cell Day.
In Ghana, the bank teamed up with the National Blood Service-Greater Accra Regional Blood Centre to host a heartfelt donation campaign that brought together staff, customers, and members of the public. Volunteers rolled up their sleeves to support sickle cell patients and others facing life-threatening conditions requiring blood transfusions.
Speaking on the significance of the initiative, Managing Director of Access Bank Ghana, Olumide Olatunji, said the bank is committed to helping the health delivery system in the country.
“This is more than a campaign. It is a lifeline. By organising this blood donation drive, we are not only saving lives but also reaffirming our commitment to creating a lasting, positive impact in the communities we serve. At Access Bank, we believe in advancing Africa—not just in the future, but right now—through bold, necessary initiatives like this,” he said.
On his part, Head of Corporate Communications & Brand Management Edward Nelson-Addy said the drive was as much about awareness as it was about action.
“We understand the emotional and physical toll that sickle cell disease takes on families across Ghana. This initiative allowed us to stand in the gap, creating hope where it’s needed most. It’s the kind of purpose-driven work that defines who we are—not just as a bank, but as a committed community partner.”
In continuation of its strategic intent to be a leading sustainability-focused Bank and build a healthy Africa, Access Bank continues to invest in the communities it operates in, delivering superior value to customers and other stakeholders. These investments, together with its sustainability commitment to impact lives now and in the future, have earned Access Bank enviable industry awards and recognitions, including the 2024 Best ESG Bank in Ghana by Euromoney and Most Innovative Bank for Community Engagement in 2023.
The Lions Club International, a non-governmental organization, has commissioned a modern diabetes clinic & emergency ward at the Suntreso Government Hospital in the Ashanti Region to provide quality health care delivery.
The facility was completed within six months, providing a much-needed space for diabetic patients who previously received treatment under a canopy and car park.
Dr. Helena Asamoah Hassan, District Governor of Lions Club International, explained that the organization built the facility to address the challenges faced by patients, particularly during rainy periods.
“We came here one day to see that where the diabetes and hypertension patients are receiving treatment is uncomfortable, so we thought it wise to build such facility for them to bridge that gap,” She said
Dr. Helena Asamoah Hassan, District Governor of Lions Club International
The fully-equipped facility costs ¢130,000 and features an outpatient department and a 10-bed emergency ward.
Dr. Thomas Agyarko-Poku, Medical Superintendent of Suntreso Government Hospital, expressed gratitude for the timely support, saying that the clinic will significantly improve healthcare delivery for diabetic patients.
“In effective health care delivery there are three things that are very important: the human resources, a place to work and the equipment we need to work with. These are very important. Today we are very grateful to Lions Club International for providing two of such important items that we need,” he stated.
Over 200 patients visit the hospital daily, and the new facility will provide a space not only for medication but also for patient education.
Otumfuo’s Mawerehene, Baffour Osei Brentuo Hyiaman V, urged healthcare workers to utilize the facility effectively and maintain it properly to ensure its longevity.
The Stephen Essoun Foundation has donated an amount of GH¢10,000 for a range of essential medical supplies to the Shai Osudoku District Hospital in the Greater Accra Region in commemoration of this year’s World Sickle Cell Day.
The donation, made on Thursday, June 19, was to support the care of sickle cell patients at the facility. The gesture forms part of the Foundation’s broader agenda to improve healthcare delivery, particularly for vulnerable groups and underserved communities.
Speaking at the event, founder Stephen Yaw Essoun, a platinum donor of the National Democratic Congress (NDC), emphasised the need for sustained public education and practical support for individuals living with sickle cell disease. “This is not just a ceremonial occasion. It is a call to action for all of us to raise awareness and provide assistance to those who endure the physical and emotional toll of this condition,” he said.
Sickle cell disease affects approximately 15,000 babies born in Ghana each year, according to estimates by the Ghana Health Service. The prevalence rate remains particularly high among certain ethnic groups, with as many as one in four Ghanaians carrying the sickle cell trait.
Hospital authorities received the items with appreciation, noting that such support is critical to delivering quality care. “We are grateful for the timely intervention by the Stephen Essoun Foundation. These supplies will go a long way in helping us maintain a clean and dignified environment for our patients,” a senior medical officer at the facility said.
Stephen Essoun
Established in 2018, the Stephen Essoun Foundation has funded over 300 scholarship placements and a series of health-focused community initiatives across the Central, Eastern, and Greater Accra Regions. In 2023, the Foundation was recognised by the West Africa Healthcare Excellence Awards for its contributions to healthcare advocacy and philanthropy.
The recent donation aligns with the global campaign by the World Health Organization to reduce stigma, improve diagnostics, and expand access to treatment for sickle cell disease, especially in sub-Saharan Africa where the disease burden remains among the highest globally.
Mr. Essoun further reaffirmed his commitment to building partnerships across the health and education sectors to address long standing inequalities in access and infrastructure.“We must not relent. Every life saved and every opportunity created is a step forward for the community,” he added.
Survival rates for childhood cancer and sickle cell disease in Ghana remain below 50%, largely due to late diagnosis, limited access to treatment, and a shortage of trained haematology professionals.
In response, World Child Cancer has launched the Strengthening Haematology Skills Project, a nationwide initiative aimed at equipping healthcare professionals with both clinical and psychosocial skills.
The programme focuses on improving the management of blood supplies while enhancing the emotional and mental support provided to patients.
These interventions are crucial for conditions such as leukemia and sickle cell disease, where blood transfusions are often life-saving.
According to Adwoa Pinamang Boateng Desu, Country Coordinator for World Child Cancer, the initiative was designed to close critical gaps in haematology care and ensure safer, more effective blood transfusions.
Supported by Bristol Myers Squibb, the project has trained 282 healthcare professionals, including 14 oncology pharmacists, using a training-of-trainers model to scale impact.
“With the ongoing challenges of transfusion reactions, limited funding, and poor management of blood disorders, we launched this project to strengthen haematology care in Ghana,” Boateng Desu explained.
She also noted that educational and communication materials on blood transfusion for sickle cell disease and leukemia were developed in collaboration with the Health Promotion Division of the Ghana Health Service to support public awareness and clinical education.
One of the major barriers to effective blood care in Ghana, however, lies in the deep-rooted myths surrounding blood donation. Misconceptions such as beliefs that donated blood is used for occult practices—have discouraged potential donors, leading to critical shortages and treatment delays. CEO of the National Blood Service, Dr. Shirley Owusu-Ofori, firmly dispelled these claims.
“Every unit of blood donated is fully traceable from the point of donation to the recipient. Even discarded units are properly accounted for. The National Blood Service does not collaborate with any spiritual or non-clinical entities. All blood is used strictly for medical purposes,” she stated. Dr. Owusu-Ofori emphasized the service’s role in rebuilding public trust through continuous media engagement and education campaigns aimed at debunking harmful myths.
As Ghana works to strengthen its healthcare infrastructure, initiatives like the Strengthening Haematology Skills Project remain vital. By investing in professional capacity and countering misinformation, the country is laying the groundwork for safer transfusions, better blood donation rates, and improved survival outcomes for patients battling leukemia, sickle cell disease, and other life-threatening conditions.
As the government prepares to vaccinate over 2.2 million young girls against the Human Papillomavirus (HPV), concerns are growing over the rising infection rates among both men and women.
The virus, known to cause cervical cancer and other serious conditions, is highly contagious and often goes undetected for years.
HPV is primarily transmitted through oral, vaginal and anal sex, as well as deep kissing. It is the leading cause of cervical cancer in women and has also been linked to anal, penile, vaginal, vulvar and throat cancers particularly through oral sex.
Ruth Katamansu, a women’s health nurse specialist at the Shai-Osudoku District Hospital in the Greater Accra Region, is at the forefront of the campaign to educate and vaccinate communities.
“HPV can go undetected for years,” she said, “and when symptoms do appear, especially in women, they may show up as small, skin-coloured warts or bumps around the vagina, often with a foul-smelling discharge.”
For men, the risks can be just as severe, sometimes resulting in significant genital damage, including rotting tissue in extreme cases.
Health experts are urging the public to adopt safe sex practices, including consistent condom use and limiting the number of sexual partners. Regular screenings, such as pap smears and HPV tests, are also strongly recommended.
Above all, doctors emphasise the power of prevention. “The HPV vaccine can prevent up to 90% of HPV-related cancers. It’s most effective when given to preteens, but it still offers protection for adults up to age 45.”
The University of Health and Allied Sciences (UHAS) has undertaken a stakeholder engagement and cancer care improvement workshop at the University’s main campus, Sokode-Lokoe, in Ho.
The event was organised with the support of the American Cancer Society Global Academy, in collaboration with the Ho Teaching Hospital (HTH) Technical Working Group, as part of the Global Healthcare Provider Support Grant initiative.
The workshop brought together medical professionals, administrators, pharmacists, nurses and researchers to discuss practical strategies to enhance cancer care and strengthen multidisciplinary collaboration within the Ho Teaching Hospital.
Professor Lydia Aziato, Vice Chancellor of UHAS, in her remarks, encouraged participants to engage partners and collaborate actively for research works, emphasising that the future of academia was tied to impactful research and meaningful collaborations.
She advocated continuous innovation, team efforts and knowledge sharing among healthcare practitioners to improve patient care outcomes.
“We make history together; we make impact together. So long as I remain the Vice Chancellor, we will continue to facilitate collaborations across departments to serve our patients better,” she said.
The Director of Medical Affairs at HTH, Dr. Emmanuel Senyo Kasu, gave a comprehensive overview of cancer management at the facility and mentioned that many people in the Volta Region remain unaware of cancer and its symptoms, which contributes to late diagnosis and limited treatment outcomes.
He stressed the importance of awareness creation and early screening as part of effective management of cancers.
Speaking on the crucial role of data, Director of Research, Policy, Planning, Monitoring and Evaluation at the hospital, Mr. Simon Dzokoto, discussed how cancer registries help in tracking incidence, treatments and outcomes. He underscored the registries value in enabling better planning, policy-making and resource allocation.
Dr. Koku Amegan-Aho, Project Lead and Head of the Department of Paediatrics and Child Health at UHAS School of Medicine, provided an update on the American Cancer Society grant and outlined key interventions under the project.
He called for comprehensive education on chemotherapy safety, adding that baseline assessments had already started.
He said, as part of ongoing efforts, a dedicated session on chemotherapy safety was scheduled for September, 2025.
He added that HTH had acquired a safety cabinet and planned to roll out educational posters, e-learning materials and training videos for staff.
He also said plans were underway to launch a specialized mobile application to guide pharmacists in drug selection and safe administration protocols.
On his part, the Quality Manager at HTH, Mr. Samuel Ahiah, emphasized the need to treat patients with dignity and equity.
He called for respectful and clear communication, advocating patients’ involvement in all decision-making processes regarding their care.
Mr. Frederick Nyaho, a Palliative Care Nurse Specialist, who made a presentation on ‘Challenges of Pain Management in Cancer Care,’ said patients often struggled to describe their pain accurately and many hold misconceptions about the use of opioids (pain relievers).
He said these challenges accounted for the suffering of excruciating pain by patients after chemotherapy sessions.
He called for increased education for both patients and healthcare providers.
A Pharmacist at HTH, Dr. James Appiah Adu Yeboah, made a presentation on the Chemosafe Initiative, underscoring the importance of appropriate Personal Protective Equipment (PPE) when handling chemotherapy drugs.
He said the safety of healthcare providers was equally as important as protecting patients.
Dr. Nelson Afram, a Senior Surgeon at HTH, who co-moderated a panel discussion during the stakeholder engagement, was officially introduced as the Chairperson for the newly established Multidisciplinary Tumor Board at the Ho Teaching Hospital.
The Board is expected to enhance coordinated cancer care by bringing together experts from various specialties to develop comprehensive treatment plans for patients.
The workshop marked another step in UHAS’ commitment to fostering research-driven healthcare delivery through strong institutional partnerships and multidisciplinary collaborations.
Alarming figures reveal that the Western Region now accounts for a staggering 71% of all confirmed Monkeypox infections nationwide.
This came to light at the Western Regional Development Retreat in Essipong on Saturday, June 21.
Kwadwo Okyere Apenteng, the Chief Pharmacist of the Western Regional Health Directorate, speaking on behalf of the Regional Health Director, underscored the severity of the situation.
He disclosed that the region documented its initial Monkeypox case on May 23 in Tarkwa, marking the beginning of an escalating outbreak.
“Monkeypox is also in the country, and currently, the Western Region is number one; we have taken over. 71% of the cases in the country are coming from the Western Region. As it stands, we have 187 suspected cases and 43 confirmed cases,” Mr Apenteng stated, highlighting the dramatic shift in the geographical distribution of the disease within Ghana.
While Ghana recorded its first Mpox (Monkeypox) cases in October 2024, the rapid concentration in the Western Region, with a population of over 2 million people (2021 Census data), presents a unique challenge for public health officials.
In response to this critical situation, the Directorate has immediately activated its public health emergency response system.
This includes intensified surveillance efforts to track potential new cases and their contacts, alongside a robust public education campaign aimed at informing residents about prevention, symptoms, and reporting mechanisms.
This aligns with Ghana’s broader National Health Security agenda, bolstered by initiatives like the recently launched $16.3 million Pandemic Fund Project, which focuses on strengthening disease surveillance, laboratory capacity, and health workforce readiness.
The current Monkeypox outbreak has also cast a harsh light on the state of healthcare infrastructure in the Western Region.
Addressing the same retreat, Western Regional Minister Joseph Nelson voiced pressing concerns about stalled healthcare projects, particularly the much-needed upgrade of the Effia Nkwanta Regional Hospital.
The hospital’s redevelopment has been a subject of public discourse for several years, with previous reports from early 2025 indicating assurances from a new government to continue the project.
However, the Regional Minister’s recent remarks suggest persistent delays.
“Our regional hospital in Effia Nkwanta is undergoing some revamping, but as we speak, the work is stalled. I pray that, very soon, work will resume so that we can complete it for the very purpose for which that project was started,” Mr Nelson lamented.
The completion of this vital regional referral facility is deemed crucial for enhancing the region’s capacity to manage not only current outbreaks like Monkeypox but also future health crises.
Recognising the severity of the situation and the critical need for improved health infrastructure, Minister Nelson extended an appeal to the Western Regional House of Chiefs.
He urged their esteemed traditional leaders to lend their considerable influence to advocacy efforts aimed at accelerating the upgrading of key health facilities throughout the region.
This collaborative approach seeks to fortify the Western Region’s preparedness and response capabilities, safeguarding the health of its citizens against emerging infectious diseases.
The Director of the Ghana Institute of Clinical Genetics (GICG), Dr. Amma Benneh-Akwasi Kuma, has issued a clarion call for collective national and global action to support individuals living with sickle cell disease, as Ghana marked both World Sickle Cell Day and 50 years of dedicated care at the GICG.
Speaking at a commemorative event held at the institute within Korle-Bu Teaching Hospital, Dr Kuma highlighted the pressing burden of sickle cell disease in Ghana and across sub-Saharan Africa, emphasising the urgent need for awareness, investment, and compassion.
“Today, the world pauses to recognise and salute the courage of over 8 million people living with sickle cell disease — and the resilience of the caregivers who walk beside them every day,” she said. “It is not just a day for awareness — it is a call to action.”
Ghana records around 18,000 new cases of sickle cell disease each year, with approximately 2% of newborns diagnosed and over half of them affected by the most severe form, Sickle Cell Anaemia. One in every three Ghanaians carries the HbS and/or HbC gene. Dr Kuma stressed that these figures are not mere statistics but a human reality that calls for sustained national attention and support.
This year’s observance was particularly symbolic, coinciding with the 50th anniversary of the GICG. Dr Kuma paid glowing tribute to the institute’s founder, the late Professor Felix Konotey-Ahulu, a pioneer in sickle cell care in Africa, who passed away just last month.
“Fifty years ago, a visionary, the late Professor Felix Konotey-Ahulu, founded this institute with one dream — that people with sickle cell disease in Ghana and across Africa could live with dignity, receive expert care, and experience hope,” she said.
Over the past five decades, the GICG has served more than 27,000 patients, contributed to groundbreaking research, and trained generations of healthcare professionals, earning its place as a beacon of excellence and compassion.
A minute’s silence was observed in honour of Professor Konotey-Ahulu, whose legacy, Dr Kuma noted, lives on “in every patient we serve, every life we save, every step forward we take.”
Dr Kuma closed her address with a strong appeal to all stakeholders to use the day not only to celebrate but to recommit to the cause.
“Let us raise our voices, shine the light on sickle cell disease, and work together to ensure that those living with it are not left behind,” she urged. “Together, we can create a future of care, compassion, and cure.”
More on Sickle Cell Disease
Sickle cell disease (SCD) is a chronic hemolytic disorder caused by a point mutation at position six of the beta-globin gene. In SCD, individuals inherit two abnormal haemoglobin genes, one of which must be haemoglobin S. Due to the inheritance of an abnormal haemoglobin, individuals with SCD—ranging from newborns to adults—face an increased risk of various complications and require multidisciplinary care.
Since the 1930s, a diverse group of individuals has initiated and advanced pediatric and adult SCD care at KBTH. Initially, care for adolescents and adults with SCD was provided in the medical block at KBTH, despite facing challenges.
The late Prof. Felix I.D. Konotey-Ahulu recognized these challenges and fought hard for individuals with genetic disorders to have their own clinic.
About GICG
In 1974, the Ghana Institute of Clinical Genetics (GICG) was established as a subvented organisation under the Ministry of Health, with the late Prof. Felix I.D. Konotey-Ahulu appointed as the first Director, and the late Dr. Michael Baddoo serving as the Director of Medical Services. When the GICG was initially founded, it received support from the VALCO Fund and the Ministry of Health, while the World Health Organization (WHO) and the International Atomic Energy Agency (IAEA) provided generous research funding, enabling the GICG to focus on service, education, and research.
In 1976, Brigadier Odartey-Wellington, the Commissioner of Health, officially commissioned the GICG, marking a significant milestone in the advancement of clinical genetics in Ghana.
After its establishment, the GICG primarily operated on an outpatient basis. Patients presenting with acute complications were admitted to the second floor of the medical block.
In the 1990s, daycare and emergency services were introduced, with outpatient and daycare services in an open area of the current outpatient department. The clinic had only a few beds and benches with mattresses to accommodate patients. Despite being understaffed and facing a high patient load, we persevered.
In the 2000s, various renovations were carried out by NGOs, institutions (both foreign and local), and SCD patient support groups. These renovations included a reception area, a general outpatient department, a new roof, wards with reclining beds for patients, and laboratory equipment.
To support its mission of providing better health management to all individuals living with SCD, GICG receives referrals from across Ghana, primarily from the southern region. Initially, GICG had a pediatric unit within the Department of Child Health at KBTH, along with an adolescent and adult unit.
All individuals diagnosed with SCD, from children to adults, were registered in the GICG registry. In the early 2010s, the pediatric SCD clinic separated from the adolescent and adult SCD clinic at GICG and became one of the specialized clinics under the Department of Child Health at KBTH.
Currently, GICG provides clinical services for adolescents (≥age 13 years) and adults, which include daily (Monday to Friday) general outpatient clinics, special clinics for disease-modifying drugs such as hydroxyurea, chronic leg ulcer treatment, and care for geriatric and renal complications. Daycare/emergency services are also available on weekdays, alongside general laboratory, public health, and pharmacy services managed by the Korle Bu Polyclinic Pharmacy. The institute has over 27,000 registered patients, with approximately 3,000 patients and 10,000 patient visits annually. The core functions of the Institute include patient care, patient/public education, and clinical research.
The Past and Present Directors of the Ghana Institute of Clinical Genetics include
Name
Year(s)
Prof. Felix I.D. Konotey-Ahulu
1974 – 1979
Dr. Akurang Dankwa
1979 – 1980
Prof. Alexander Bruce-Tagoe
1980 – 1984
Prof. Rev. George Ankrah-Badu
1984 – 1988, 1990 -1994
Prof. Joseph Kpakpo Acquaye
1988 – 1990, 1994 – 2002
Prof. Ivy Ekem
2002 – 2014
Prof. Edeghonghon O. Olayemi
2014 – 2017
Prof. Yvonne Akotoa Dei-Adomakoh
2017 – 2022
Dr Amma Anima Benneh-Akwasi Kuma
2022 – present
Other doctors who have sacrificed for the care of individuals with SCD include the late Dr. Gabriel G. Ampomah Twumasi and Dr. Fredericka Sey.
The past and current staff and patients of GICG have also played an instrumental role in caring for our patients and in groundbreaking global clinical trials for SCD, placing the institute on the world map for SCD.
The Focus on Sickle Cell Foundation (FoSCel) has held a national forum uniting stakeholders from across health, education, and civil society in a call to address Sickle Cell Disease (SCD) in Ghana.
Organised to mark World Sickle Cell Day, the event held at the University of Education, Winneba (UEW), and themed “Know Your Genotype, Secure the Future”, brought together students, health professionals, traditional leaders, government representatives, and NGOs for a national dialogue on one of Ghana’s most pressing yet under-discussed health challenges.
Founder of FoSCel, journalist and advocate Amos Andoh (Akokoa Mpaninsem), shared his own experience of living with Sickle Cell Disease, saying “This is more than a project for me – it is a mission born of pain but driven by purpose.”
He stressed the urgent need for education, revealing that a significant portion of the Ghanaian population remains unaware of basic facts about the disease, including genotype compatibility and transmission.
In his keynote address, guest speaker Dr Anyemedu Asare Fredovich, an orthopaedic surgeon and former Acting Medical Director of the Trauma and Specialist Hospital in Winneba, described the global death toll from Sickle Cell as “a daily aviation disaster we are not talking about.”
Dr Fredovich revealed startling national statistics, noting that 2% of all babies born in Ghana each year — about 15,000 to 20,000 infants — have Sickle Cell Disease, while 15% to 30% of the population are genetic carriers.
He warned that a lack of public awareness around genotype compatibility continues to drive the crisis.
“We’re losing lives unnecessarily because people simply do not know their genotype or what it means for their future families,” he said, commending FoSCel for stepping into a leadership role and expressing hope that the foundation becomes the “linchpin” of a more coordinated, long-term national response.
The forum featured panel discussions on the psychological, social, and economic impact of Sickle Cell Disease, with contributions from the Ghana Health Service, the Ministry of Health, the university faculty, and traditional councils.
The sessions explored treatment barriers, stigma, and strategies to improve support systems for affected families.
Student voices were particularly prominent, with youth leaders pledging to intensify peer education campaigns, ensuring their networks embrace early genotype testing and informed reproductive choices.
“This generation can break the cycle, but we must be informed first,” one student leader remarked during an open forum session.
A symbolic candle-lighting ceremony was held in memory of lives lost to SCD, capping off a day of reflection, advocacy, and renewed commitment.
FoSCel announced it would expand its national outreach campaign, with upcoming forums scheduled at major universities including the University of Ghana, KNUST, UCC, and UDS.
